Literature DB >> 30604500

Frequency of ABO/Rhesus (D) blood groupings and ethnic distribution in the Greater-Accra region of Ghana, towards effective blood bank inventory.

George Narh Doku1, William Kweku Agbozo1, Rabia Asiba Annor1, Gladis Doeyo Kisseh1, Matilda Ampomah Owusu1.   

Abstract

Knowledge on blood group phenotypes is of key importance in clinical practice. It used in blood transfusion practice to determine the direction of recruitment of voluntary donors as required for each population within a country, and for disease association and population genetics studies. This study aimed at reporting the frequency of ABO and Rhesus (Rh) groups in the population of the Greater-Accra region of Ghana and amongst their various ethnic groups. A retrospective study in 11 main hospitals within the region was done. Data collected provided information on the blood group status of persons (both blood donors and recipients) who visited the selected hospitals. Medical records used were within the years 2012-2017. A total of 42,317 (26,802 males and 15,515 females) data were retrieved and analysed. The frequencies of the blood groups O, A, B and AB were 50.0%, 24.3%, 20.7% and 5.0%, respectively. Rhesus-positive to negative ratio was 93.2%/6.2%. Frequencies of blood group O was highest (49.1%-53.6%) in all ethnic groups. The second most dominant blood group was B (24.2%-25.4%) in the Ga-Adamgbe, Akan and Ewe ethnic groups, whilst blood group A (25.0%-26.9%) was the second most dominant in the Northerners and non-Ghanaians. Blood group distribution amongst gender and different age groups showed no significant differences but followed the same pattern for the general population. The study provides data on the ethnic distribution and frequency of ABO and Rhesus blood groupings in the Greater-Accra region of Ghana. It also informs the need for blood banks in the region to increase the proportion of stockpiled Rhesus-positive blood groups especially for O, B and A that may be high in demand.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  ABO; Ghana; Greater-Accra; Rhesus; blood grouping

Mesh:

Substances:

Year:  2019        PMID: 30604500     DOI: 10.1111/iji.12412

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  5 in total

1.  ABO and Rhesus Blood Group Distribution in Mogadishu, Somalia.

Authors:  Tufan Ermiş; Nasro Ahmed Adan; Abdiqani Nor Gacal; Ramlo Ahmed Noh; Ebubekir Arslan
Journal:  J Blood Med       Date:  2022-05-03

2.  Asymptomatic carriage of Plasmodium falciparum by individuals with variant blood groups and haemoglobin genotypes in southern Ghana.

Authors:  Festus K Acquah; Dickson Donu; Dorcas Bredu; Sophia Eyia-Ampah; Jones A Amponsah; Joseph Quartey; Evans K Obboh; Bernice A Mawuli; Linda E Amoah
Journal:  Malar J       Date:  2020-06-23       Impact factor: 2.979

3.  Distribution and Frequency of ABO and Rhesus (D) Blood Groups in Somalia: A Retrospective Study on Students of Jazeera University, Mogadishu-Somalia.

Authors:  Mohamed Hayir Tahlil Mohamud; Abdullah Dahir H Aweis; Abdiwahab Sheikh Elmi Adam; Farhia Abdullahi Mohamed; Safia Qasim Fidow; Lul Mohamud Mohamed
Journal:  Biomed Res Int       Date:  2022-01-30       Impact factor: 3.411

4.  Frequencies and ethnic distribution of ABO and RhD blood groups in the Volta region of Ghana, towards effective blood bank services.

Authors:  George N Doku; William K Agbozo; Rabia A Annor; Priscilla E Mawudzro; Elizabeth E Agbeli
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

5.  Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa.

Authors:  Kesego Tapela; Fatima O Oyawoye; Charles Ochieng' Olwal; Precious C Opurum; Jones Amo Amponsah; Kekeli Aku Lumor Segbedzi; Becky Tetteh; Frederick Kumi-Ansah; Joe K Mutungi; Evangeline Obodai; Emmanuella Amoako; Seth Agyemang; Nicaise Tuikue Ndam; William Kwabena Ampofo; Julian C Rayner; Gordon A Awandare; Lily Paemka; Yaw Bediako; Peter Kojo Quashie
Journal:  BMC Med       Date:  2022-10-03       Impact factor: 11.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.